Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…
Read more »
By
AmyT on
October 27, 2009
There are so many great events around empowered patients and consumer-driven healthcare in the Fall. It also being soccer season, the kickoff of the school year, and time for nearly every existing Jewish holiday, I can’t possibly attend as many as I’d like to. This makes me especially thankful to have some good D-blogger friends, such as Allison Blass, who recently attended one of these key conferences, and reports back to DiabetesMine today:
A Guest…
Read more »
Forget about risk factors: nothing gives people the “diabetes wake-up call” like getting diagnosed yourself — or living through it with a loved one. The latter is what happened recently to Academy-Award winner Olympia Dukakis, whose husband Louis Zorich was diagnosed with type 2 diabetes last winter.
Suddenly, diabetes awareness was a top-of-mind issue for the couple, as they realized that early screening may have saved Louis’ life and limb. Olympia has joined forces with Novo…
Read more »
By
AmyT on
December 11, 2008
There are a lot of things going on at the troubled Food and Drug Administration right now that could have a profound impact on the future of diabetes care, but most of us patients never hear about them. And that’s a damn shame. Because we stand at a crossroads.
You may or may not be aware that the Obama Administration is about to appoint a new FDA Commissioner. The politics and personal leanings of this…
Read more »
By
AmyT on
October 16, 2008
Who here uses an insulin pen? Tired of having to screw the needles on and off? You might be very interested a new product from Can-Am Care called ClickFine, precision Swiss-made pen needles with patented technology that lets you click them on and off instantly.
What’s the big deal, you ask? Well, I personally switched from a Novo Nordisk Junior pen to an insulin pump about a year and a half ago, but I do…
Read more »
